| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/13510002.2017.1325571 |
| P698 | PubMed publication ID | 28521618 |
| P50 | author | Marta Niwald | Q57560574 |
| Michał Bijak | Q61150133 | ||
| Elżbieta Miller | Q87774930 | ||
| P2093 | author name string | Joanna Saluk | |
| Agnieszka Morel | |||
| P2860 | cites work | Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients. | Q48709361 |
| Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis | Q48825272 | ||
| Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients | Q48960802 | ||
| Peripheral markers in neurodegenerative patients and their first-degree relatives. | Q50778792 | ||
| Elevated levels of carbonyl proteins in cerebrospinal fluid of patients with neurodegenerative diseases. | Q53643766 | ||
| Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers | Q57647010 | ||
| Defining the clinical course of multiple sclerosis: Results of an international survey | Q22241638 | ||
| Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria | Q24605493 | ||
| Tissue sulfhydryl groups | Q26778486 | ||
| Clinical Relevance of Biomarkers of Oxidative Stress | Q26785512 | ||
| ROS and brain diseases: the good, the bad, and the ugly | Q27014070 | ||
| Multiple sclerosis: molecular mechanisms and therapeutic opportunities | Q27023735 | ||
| New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis | Q28072844 | ||
| 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method | Q28379340 | ||
| Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome | Q29030741 | ||
| Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis | Q30988577 | ||
| Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis | Q33481896 | ||
| Role of the innate immune system in the pathogenesis of multiple sclerosis | Q33787624 | ||
| Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry. | Q33877162 | ||
| Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis | Q34769676 | ||
| Multiple sclerosis: an immune or neurodegenerative disorder? | Q34786872 | ||
| Oxidative damage in multiple sclerosis lesions | Q35065674 | ||
| Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage | Q35598836 | ||
| A prospective web-based patient-centred interactive study of long-term disabilities, disabilities perception and health-related quality of life in patients with multiple sclerosis in The Netherlands: the Dutch Multiple Sclerosis Study protocol | Q35736039 | ||
| The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis. | Q36027486 | ||
| Role of reactive nitrogen species in blood platelet functions | Q36939640 | ||
| Cause and prevention of demyelination in a model multiple sclerosis lesion. | Q37105517 | ||
| Is multiple sclerosis a mitochondrial disease? | Q37466077 | ||
| Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities | Q37605018 | ||
| Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment | Q37699846 | ||
| The immunopathophysiology of multiple sclerosis | Q37857982 | ||
| The molecular basis of neurodegeneration in multiple sclerosis | Q37920009 | ||
| Advances in antioxidative therapy of multiple sclerosis | Q38120002 | ||
| Initial immunopathogenesis of multiple sclerosis: innate immune response. | Q38156767 | ||
| A comparative evaluation of the response to peroxynitrite by a brain endothelial cell line and control of the effects by drug targeting | Q39866917 | ||
| Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies | Q41136886 | ||
| Intracellular and extracellular sulphydryl levels in rheumatoid arthritis | Q41150990 | ||
| Multiple sclerosis and the blood-central nervous system barrier | Q43136157 | ||
| The serum protein and lipid oxidation marker levels in Alzheimer's disease and effects of cholinesterase inhibitors and antipsychotic drugs therapy | Q43204113 | ||
| Increased risk of ischaemic stroke among patients with multiple sclerosis | Q43696444 | ||
| Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis | Q44776045 | ||
| High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein. | Q46781171 | ||
| Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis | Q46826911 | ||
| Plasma lipid peroxidation and progression of disability in multiple sclerosis. | Q48201059 | ||
| P433 | issue | 6 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| secondary progressive multiple sclerosis | Q18965511 | ||
| P304 | page(s) | 547-555 | |
| P577 | publication date | 2017-05-19 | |
| P1433 | published in | Redox Report | Q15758836 |
| P1476 | title | Markers of oxidative/nitrative damage of plasma proteins correlated with EDSS and BDI scores in patients with secondary progressive multiple sclerosis | |
| P478 | volume | 22 |
| Q97523765 | Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis | cites work | P2860 |
Search more.